CYC1 Predicts Poor Prognosis in Patients with Breast Cancer

Figure 3

Proliferation of breast cancer cells is suppressed by CYC1 knockdown. Cell proliferation was assessed with a CFSE assay in MDA-MB-231 due to CYC1 siRNA (a). After treatment with CYC1 siRNA, cell cycle distribution of MDA-MB-231 via flow cytometry analysis was shown (b).

(a)

(b)